VESIcare Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions:   Sjogren's Syndrome;   Overactive Bladder Syndrome Interventions:   Drug: mirabegron;   Drug: oxybutynin, tolterodine, solifenacin Sponsor:   China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials

Efficacy of Low-intensity Shock Wave Therapy on Persistent Storage Symptoms After Transurethral Surgery for Benign Prostatic Obstruction
Conditions:   Overactive Bladder;   Urinary Incontinence, Urge;   Urgency-frequency Syndrome;   Post Prostatectomy Interventions:   Procedure: Li-SWT (suprapubic approach);   Procedure: Li-SWT (perineal approach);   Procedure: Li-SWT (combined approach);   Procedure: Sham treatment;   Drug: Solifenacin Sponsor:   Mansoura University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2020 Category: Research Source Type: clinical trials